About this trial
Last updated 2 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 9 months ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Children aged between 7 and 15 years.
- VA in the amblyopic eye < 0.1 logMAR units.
- Interocular difference in VA ≥ 1 logMAR line.
- Interocular difference in espherical equivalent ≥ 1 D.
- Interpupillary distance (IPD) between 60.7 and 73.5 mm.
- Use of best refractive correction for at least 2 months prior to inclusion.
- Lack of response or therapeutic adherence to conventional occlusion therapy.
- Willingness to attend all the active vision therapy sessions and/or visits of the study.
- No history of previous treatment for amblyopia other than optimal refractive correction for at least 2 months prior to inclusion.
Exclusion Criteria
- Active eye disease.
- Previous ocular surgery.
- BCVA in the amblyopic eye of ≥ 0.70 logMAR.
- Presence of cognitive impairment or neurological or psychiatric disorders.
- Presence of irregular cornea due to astigmatism or ectatic corneal disease.